Bangladesh is a low income country with the population of 150.5 million. TB remains a major public health problem in Bangladesh: the country is among both high TB and high MDR-TB burden countries. More than 170,000 cases of TB including 106,790 smear positives were notified in 2012. Approximately, 70,000 people die from TB every year. The estimated MDR-TB burden is 1.4% among the new and 29% among the retreatment cases. (WHO World TB report 2013).
DOTS represents the best strategy for coordinating TB services within the broader health system, mobilizing wide support at the operational level, reducing TB incidence, and preventing further drug resistance.
Programmatic Management of Drug-resistant TB (PMDT): While the causes of multi-drug resistant TB are similar in all high burden countries (low adherence, weak DOTS, poor treatment compliance, inadequate drug supplies, direct transmission, etc.).
TB / HIV
TB CARE II works to link HIV and TB advocacy and to promote a unified response, and works with National TB and HIV/AIDS Programs to integrate planning and service delivery mechanisms to effectively tackle the dual epidemics.
Health Systems Strengthening
TB CARE II supports health systems improvement through our country programs, emphasizing management capacity building, integration, and results-oriented process improvement.